Articles| App notes / Features / Science success stories / Interviews / White papers
Take a deep dive into some of the latest scientific findings and learn about the scientists, methods, and techniques that made them possible.
Predicting and Overcoming Resistance Using IsoPlexis' Single-Cell Intracellular Proteomic and Metabolomic Analysis Tools
IsoPlexis | Sep 11, 2020 | 3 min read
Cancer cells develop resistance to targeted therapies, and their inherent functional heterogeneity makes it difficult for researchers to understand and characterize these resistance mechanisms. IsoPlexis' single-cell proteomics is helping researchers overcome resistance to targeted inhibitors, leading to better strategies and combination therapies.
Combating COVID-19 with Cell-Free Expression
The Scientist | Aug 19, 2020 | 6 min read
Scientists rely on synthetic biology and cell-free expression systems for developing novel approaches to combat the pandemic.
Tailor-Made: Empowering SARS-CoV-2 Researchers Worldwide
The Scientist | May 26, 2020 | 2 min read
Arbor Biosciences is offering free SARS-CoV-2 myBaits kits to all researchers.
Chemyx: Navigating Legal and Regulatory Requirements for Cannabis Research and Product Development in the United States
Chemyx Inc. | Dec 4, 2019 | 3 min read
Given its legal status as a controlled substance, researchers, producers, and developers still must be aware of a considerable number of regulatory guidelines and practices governing the cannabis industry.
Chemyx: Cannabis Extraction on the Cutting Edge
Chemyx Inc. | Dec 3, 2019 | 3 min read
Tully Stroud, Chief Scientific Officer for Elite Molecular Labs, talks about the growing field of cannabis extraction and refinement.
How single cell proteomics data can drive CAR-Treg-based therapies—an interview with Leonardo Ferreira
IsoPlexis | Oct 18, 2019 | 3 min read
Leonardo Ferreira, a postdoctoral fellow at the University of California, San Francisco, discusses the application of single cell proteomics data to understanding the function and therapeutic potential of genetically engineered regulatory T cells.
Understanding T-cell polyfunctionality: How single cell proteomics data drive CAR-T cell therapy research and development
IsoPlexis | Oct 7, 2019 | 3 min read
Vladimir Senyukov, Director of BioAnalytical Development at Precision Biosciences, talks about investigating T-cell cytokine production using single cell proteomics in order to unlock the therapeutic potential of allogeneic CAR-T cells.